Dietary Probiotic GKA4, Dead Probiotic GKA4, and Postbiotic GKA4 Improves Cisplatin-Induced AKI by Autophagy and Endoplasmic Reticulum Stress and Organic Ion Transporters

Overview

Journal Nutrients

Date 2024 Oct 26

PMID 39458526

Authors

Jaung-Geng Lin

Wen-Ping Jiang

You-Shan Tsai

Shih-Wei Lin

Yen-Lien Chen

Chin-Chu Chen

Guan-Jhong Huang

Affiliations

Soon will be listed here.

Abstract

Background/objectives: Acute kidney injury (AKI) syndrome is distinguished by a quick decline in renal excretory capacity and usually diagnosed by the presence of elevated nitrogen metabolism end products and/or diminished urine output. AKI frequently occurs in hospital patients, and there are no existing specific treatments available to diminish its occurrence or expedite recovery. For an extended period in the food industry, has been distinguished by its robust bacteriocin production, effectively inhibiting pathogen growth during fermentation and storage.

Methods: In this study, the aim is to assess the effectiveness of GKA4, dead probiotic GKA4, and postbiotic GKA4 against cisplatin-induced AKI in an animal model. The experimental protocol involves a ten-day oral administration of GKA4, dead probiotic GKA4, and postbiotic GKA4 to mice, with a cisplatin intraperitoneal injection being given on the seventh day to induce AKI.

Results: The findings indicated the significant alleviation of the renal histopathological changes and serum biomarkers of GKA4, dead probiotic GKA4, and postbiotic GKA4 in cisplatin-induced nephrotoxicity. GKA4, dead probiotic GKA4, and postbiotic GKA4 elevated the expression levels of HO-1 and decreased the expression levels of Nrf-2 proteins. In addition, the administration of GKA4, dead probiotic GKA4, and postbiotic GKA4 significantly reduced the expression of apoptosis-related proteins (Bax, Bcl-2, and caspase 3), autophagy-related proteins (LC3B, p62, and Beclin1), and endoplasmic reticulum (ER) stress-related proteins (GRP78, PERK, ATF-6, IRE1, CHOP, and Caspase 12) in kidney tissues. Notably, GKA4, dead probiotic GKA4, and postbiotic GKA4 also upregulated the levels of proteins related to organic anion transporters and organic cation transporters.

Conclusions: Overall, the potential therapeutic benefits of GKA4, dead probiotic GKA4, and postbiotic GKA4 are significant, particularly after cisplatin treatment. This is achieved by modulating apoptosis, autophagy, ER stress, and transporter proteins to alleviate oxidative stress.

References

Kim J, Kim J, Lee K, Lee H . Cancer chemopreventive effects of lactic acid bacteria. J Microbiol Biotechnol. 2007; 17(8):1227-35. View

Liu J, Lu J, McKeage M . Membrane transporters as determinants of the pharmacology of platinum anticancer drugs. Curr Cancer Drug Targets. 2012; 12(8):962-86. DOI: 10.2174/156800912803251199. View

Kursad Incili G, Karatepe P, Akgol M, Kaya B, Kanmaz H, Hayaloglu A . Characterization of Pediococcus acidilactici postbiotic and impact of postbiotic-fortified chitosan coating on the microbial and chemical quality of chicken breast fillets. Int J Biol Macromol. 2021; 184:429-437. DOI: 10.1016/j.ijbiomac.2021.06.106. View

Tang C, Livingston M, Safirstein R, Dong Z . Cisplatin nephrotoxicity: new insights and therapeutic implications. Nat Rev Nephrol. 2022; 19(1):53-72. DOI: 10.1038/s41581-022-00631-7. View

Perse M, Veceric-Haler Z . Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges. Biomed Res Int. 2018; 2018:1462802. PMC: 6157122. DOI: 10.1155/2018/1462802. View

Meruvu H, Harsa S . Lactic acid bacteria: isolation-characterization approaches and industrial applications. Crit Rev Food Sci Nutr. 2022; 63(26):8337-8356. DOI: 10.1080/10408398.2022.2054936. View

Bernal-Barquero C, Vazquez-Zapien G, Mata-Miranda M . Review of alterations in gene expression and apoptotic pathways caused in nephrotoxicity induced by cisplatin. Nefrologia (Engl Ed). 2019; 39(4):362-371. DOI: 10.1016/j.nefro.2018.11.012. View

Xu Y, Wang C, Li Z . A new strategy of promoting cisplatin chemotherapeutic efficiency by targeting endoplasmic reticulum stress. Mol Clin Oncol. 2014; 2(1):3-7. PMC: 3916193. DOI: 10.3892/mco.2013.202. View

Gao J, Deng Q, Yu J, Wang C, Wei W . Role of renal tubular epithelial cells and macrophages in cisplatin-induced acute renal injury. Life Sci. 2024; 339:122450. DOI: 10.1016/j.lfs.2024.122450. View

10.

Kaushal G, Shah S . Autophagy in acute kidney injury. Kidney Int. 2016; 89(4):779-91. PMC: 4801755. DOI: 10.1016/j.kint.2015.11.021. View

11.

Ratliff B, Abdulmahdi W, Pawar R, Wolin M . Oxidant Mechanisms in Renal Injury and Disease. Antioxid Redox Signal. 2016; 25(3):119-46. PMC: 4948213. DOI: 10.1089/ars.2016.6665. View

12.

Ghosh S . Cisplatin: The first metal based anticancer drug. Bioorg Chem. 2019; 88:102925. DOI: 10.1016/j.bioorg.2019.102925. View

13.

Skrypnyk N, Siskind L, Faubel S, de Caestecker M . Bridging translation for acute kidney injury with better preclinical modeling of human disease. Am J Physiol Renal Physiol. 2016; 310(10):F972-84. PMC: 4889323. DOI: 10.1152/ajprenal.00552.2015. View

14.

Chien L, Wu C, Deng J, Jiang W, Huang W, Huang G . Salvianolic Acid C Protects against Cisplatin-Induced Acute Kidney Injury through Attenuation of Inflammation, Oxidative Stress and Apoptotic Effects and Activation of the CaMKK-AMPK-Sirt1-Associated Signaling Pathway in Mouse Models. Antioxidants (Basel). 2021; 10(10). PMC: 8533075. DOI: 10.3390/antiox10101620. View

15.

Lee M, Chung J, Kim K, Im W, Kim M . Two-weeks repeated-dose oral toxicity study of Pediococcus acidilactici J9 in a mice model. BMC Microbiol. 2020; 20(1):372. PMC: 7727177. DOI: 10.1186/s12866-020-02055-4. View

16.

Lin W, Jiang W, Chen C, Lee L, Tsai Y, Chien L . Renoprotective Effect of GKA4 on Cisplatin-Induced Acute Kidney Injury by Mitigating Inflammation and Oxidative Stress and Regulating the MAPK, AMPK/SIRT1/NF-κB, and PI3K/AKT Pathways. Nutrients. 2022; 14(14). PMC: 9323173. DOI: 10.3390/nu14142877. View

17.

Dasari S, Njiki S, Mbemi A, Yedjou C, Tchounwou P . Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy. Int J Mol Sci. 2022; 23(3). PMC: 8835907. DOI: 10.3390/ijms23031532. View

18.

Holditch S, Brown C, Lombardi A, Nguyen K, Edelstein C . Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury. Int J Mol Sci. 2019; 20(12). PMC: 6627318. DOI: 10.3390/ijms20123011. View

19.

Duann P, Lianos E, Ma J, Lin P . Autophagy, Innate Immunity and Tissue Repair in Acute Kidney Injury. Int J Mol Sci. 2016; 17(5). PMC: 4881488. DOI: 10.3390/ijms17050662. View

20.

McSweeney K, Kate Gadanec L, Qaradakhi T, Ali B, Zulli A, Apostolopoulos V . Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations. Cancers (Basel). 2021; 13(7). PMC: 8036620. DOI: 10.3390/cancers13071572. View